🇺🇸 ROIV — Roivant Sciences Ltd.

Salud Compra fuerte
← Volver

Precio actual

36,04 USD

Máx. histórico

41,81

55 días

Caída desde máximo

-13,80%

Rango 52 semanas

19,32 – 42,50

Variación hoy

+0,42%

Cierre anterior

35,89

Rango de hoy

35,56 – 36,78

Volumen hoy

6.686.435

Peor caída histórica

-79,22%

20/12/2021 → 12/05/2022

Recuperado en 1217 días

Volatilidad anualizada ⓘ

55,48%

Información
Nombre completo
Roivant Sciences Ltd.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Biotechnology
Empleados
721
PER ⓘ
—
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
50,00 USD (puede no estar actualizado)
Primera cotización
08/12/2020
Precio actualizado
hace 9 horas
Sobre la empresa

Roivant Sciences Ltd., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines and technologies. Its clinical product candidates include IMVT-1402, a fully human monoclonal antibody targeting FcRn in development across several IgG-mediated autoimmune indications; mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease; neonatal fragment crystallizable receptor for the treatment of graves' disease, difficult-to-treat rheumatoid arthritis, sjögren's disease, myasthenia gravis, chronic inflammatory demyelinating polyneuropathy, and cutaneous lupus erythematosus indications; batoclimab, a fully human monoclonal antibody for the treatment of thyroid eye disease; and brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis, cutaneous sarcoidosis, and other immune-mediated diseases. The company's lead program consists of mosliciguat, an inhaled sGC activator for the treatment of pulmonary hypertension associated with interstitial lung disease and other cardiopulmonary diseases. In addition, the company offers delivery platforms comprising a lipid nanoparticle (LNP) platform and a ligand conjugate platform. Roivant Sciences Ltd. was founded in 2014 and is based in London, United Kingdom.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
05/01/2023 7,71 8,24 7,55 8,14 +7,67% 8,95% 3.498.900
04/01/2023 7,45 7,61 6,65 7,56 +5,73% 12,89% 4.089.200
03/01/2023 8,08 8,10 7,11 7,15 -10,51% 12,25% 2.333.700
30/12/2022 7,67 8,01 7,62 7,99 +1,40% 5,08% 2.192.900
29/12/2022 7,71 7,97 7,53 7,88 +3,28% 5,71% 1.965.000
28/12/2022 7,60 7,73 7,39 7,63 +1,06% 4,54% 1.178.200
27/12/2022 7,05 7,77 7,05 7,55 +7,70% 10,21% 2.754.600
23/12/2022 7,10 7,37 6,92 7,01 -2,64% 6,34% 1.710.400
22/12/2022 7,19 7,25 6,99 7,20 -0,69% 3,62% 1.292.600
21/12/2022 7,09 7,27 6,94 7,25 +2,26% 4,58% 1.793.200
20/12/2022 6,47 7,16 6,47 7,09 +7,59% 10,66% 1.526.800
19/12/2022 7,38 7,38 6,43 6,59 -9,97% 12,87% 2.244.000
16/12/2022 7,21 7,53 7,14 7,32 +1,10% 5,40% 7.592.000
15/12/2022 7,24 7,35 7,18 7,24 +0,28% 2,28% 2.048.700
14/12/2022 6,96 7,30 6,89 7,22 +3,74% 5,89% 1.994.300
13/12/2022 7,25 7,31 6,93 6,96 -1,83% 5,24% 1.671.400
12/12/2022 6,99 7,20 6,89 7,09 +1,29% 4,43% 2.223.500
09/12/2022 6,84 7,11 6,83 7,00 +0,29% 4,09% 2.524.300
08/12/2022 6,62 7,01 6,56 6,98 +5,76% 6,78% 2.410.300
07/12/2022 6,82 7,00 6,39 6,60 +4,27% 8,94% 5.392.600
06/12/2022 6,16 6,41 5,99 6,33 +2,43% 6,90% 1.579.500
05/12/2022 6,42 6,47 6,04 6,18 -1,90% 6,70% 1.725.700
02/12/2022 5,80 6,32 5,65 6,30 +8,62% 11,55% 2.618.300
01/12/2022 5,75 5,92 5,24 5,80 +8,21% 11,83% 3.148.800
30/11/2022 5,14 5,39 5,07 5,36 +4,89% 6,23% 2.421.100
29/11/2022 5,02 5,25 5,01 5,11 +1,39% 4,80% 888.500
28/11/2022 5,12 5,27 4,98 5,04 -2,33% 5,57% 963.700
25/11/2022 5,13 5,23 5,10 5,16 +0,39% 2,53% 325.500
23/11/2022 4,89 5,29 4,89 5,14 +4,47% 8,18% 870.500
22/11/2022 4,82 4,93 4,71 4,92 +1,86% 4,56% 871.800